Vaccination Against Angiogenesis-Associated Antigens: A Novel Cancer Immunotherapy Strategy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|3|8|773-779

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.3, Iss.8, 2003-12, pp. : 773-779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens

By Schultze J.L.   Vonderheide R.H.  

Trends in Immunology, Vol. 22, Iss. 9, 2001-09 ,pp. : 516-523

Elsevier

Access to resources Recommend Favorite

Autoantibodies to Tumor-Associated Antigens as Cancer Biomarkers

By  

Current Molecular Medicine, Vol. 10, Iss. 2, 2010-03 ,pp. : 115-122

Bentham Science Publishers

Access to resources Recommend Favorite

A translational bridge to cancer immunotherapy: Exploiting costimulation and target antigens for active and passive T cell immunotherapy

By Vonderheide Robert   June Carl  

Immunologic Research, Vol. 27, Iss. 2-3, 2003-06 ,pp. : 341-355

Humana Press, Inc

Access to resources Recommend Favorite

Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer

By Morrow Matthew P   Yan Jian   Sardesai Niranjan Y  

Expert Review of Vaccines, Vol. 12, Iss. 3, 2013-03 ,pp. : 271-283

Informa Healthcare

Access to resources Recommend Favorite

Integrating a `danger' signal into molecular chaperoning to improve vaccination against cancer

By Yu Xiaofei   Subjeck John R   Wang Xiang-Yang  

Expert Review of Vaccines, Vol. 12, Iss. 6, 2013-06 ,pp. : 581-583

Informa Healthcare

Access to resources Recommend Favorite